ClinicalTrials.Veeva

Menu

Surviving Pneumonia

N

Nordsjaellands Hospital

Status

Enrolling

Conditions

Community-acquired Pneumonia

Treatments

Other: No intervention

Study type

Observational

Funder types

Other

Identifiers

NCT03795662
Surviving Pneumonia

Details and patient eligibility

About

The study aims to explore risk factors for poor prognosis among patients admitted with community-acquired pneumonia (CAP). During a 5-year study period, all patients (aged ≥ 18 years) admitted with CAP at North Zealand Hospital will be invited for inclusion. Questionnaires, anthropometric measures, laboratory tests, and biomaterials will be collected at admission, daily during admission, at discharge and at follow-up. The main clinical outcomes of the study consist of deaths and development of diabetes.

Enrollment

2,500 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Infiltrate on chest radiograph plus one or more of the following:

    • Fever (temperature, ≥38.0°C)
    • Hypothermia (<35.0°C),
    • New cough with or without sputum production
    • Pleuritic chest pain
    • Dyspnea
    • Altered breath sounds on auscultation.

Exclusion criteria

  • Patients unable to give informed consent
  • Patients unwilling to give informed consent

Trial design

2,500 participants in 1 patient group

Community-acquired pneumonia
Description:
Adults over 18 years old admitted with confirmed community-acquired pneumonia.
Treatment:
Other: No intervention

Trial contacts and locations

1

Loading...

Central trial contact

Maria Hegelund, MSc; Camilla Ryrsø, MSc

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems